Dave Sloane
About Dave Sloane
Dave Sloane is the Executive Director of Process Development at Nektar Therapeutics, where he has worked since 2021. He has extensive experience in the biotechnology field, having held various roles in both small and large pharmaceutical companies, and focuses on developing biological therapies for unmet medical needs.
Work at Nektar Therapeutics
Dave Sloane currently serves as the Executive Director of Process Development at Nektar Therapeutics, a position he has held since 2021. In this role, he focuses on developing biological therapies aimed at addressing unmet medical needs. His responsibilities include leading cross-functional teams that bridge the gap between development and manufacturing processes. Sloane's experience at Nektar builds on his previous tenure as Sr. Director of Protein Therapeutics from 2017 to 2020, where he contributed to the advancement of therapeutic proteins.
Education and Expertise
Dave Sloane holds a PhD in Molecular Biology from the University of California, Berkeley, where he studied from 1982 to 1988. He also earned a BA in Biology from UC San Diego, completing his studies there from 1976 to 1980. His educational background provides a strong foundation for his extensive experience in the biotechnology and pharmaceutical sectors, particularly in developing biological therapies and leading teams in both research and manufacturing environments.
Background
Dave Sloane has a diverse professional background, having worked in various capacities across multiple organizations. He began his career as a Post-doctoral researcher at UCSF from 1989 to 1992. He then held positions as a Scientist at Syntex from 1992 to 1995, a Sr. Scientist at Chiron from 2000 to 2004, and an Associate Director at Rinat Laboratories from 2004 to 2008. His experience spans both small biotech firms and large pharmaceutical companies, providing him with a broad perspective on the industry.
Previous Positions and Experience
Before joining Nektar Therapeutics, Dave Sloane held significant roles in various organizations. He worked as a Scientist at Targeted Genetics from 1996 to 2000, and later as a Sr. Director at Catalyst Biosciences from 2008 to 2016. His tenure at Chiron and Rinat Laboratories further solidified his expertise in the field. Sloane's experience encompasses both discovery research and GMP manufacturing, showcasing his ability to adapt to different environments and challenges.